Skip to main content
SpringerLink
Log in

Primary Central Nervous System Lymphomas: Salvage Treatment

  • Chapter
  • First Online:
Methods of Cancer Diagnosis, Therapy, and Prognosis

Part of the book series: Methods of Cancer Diagnosis, Therapy and Prognosis ((HAYAT,volume 8))

  • 1167 Accesses

Abstract

Primary central nervous system lymphoma (PCNSL) is a rare subtype of extranodal non-Hodgkin lymphoma (NHL) that arises from the brain parenchyma, eyes, cerebrospinal fluid, meninges or spinal cord without evidence of systemic spread. It has had an increase during last 3 decades, accounting for ∼3% of all CNS malignancies in the United States from 1998 to 2002.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

REFERENCES

  • Abrey, L.E., Deangelis, L.M., and Yahalom, J. (1998) Long-term survival in primary CNS lymphoma. J. Clin. Oncol. 16:859–863

    PubMed  CAS  Google Scholar 

  • Abrey, L.E., Ben-Porat, L., Panageas, K.S., Yahalom, J., Berkey, B., Curran, W., Schultz, C., Leibel, S., Nelson, D., Mehta, M., and DeAngelis, L.M. (2006) Primary central nervous system lymphoma: the Memorial Sloan-Kettering Cancer Center prognostic model. J. Clin. Oncol. 24:5711–5715

    Article  PubMed  Google Scholar 

  • Altman, J.K., Tellez, C., Chandler, J., Levy, R.M., Getch, C., Cohn, R., Gallot, L., Marymont, M., Grimm, S.A., and Raizer, J.J. (2008) Phase II trial of recurrent primary CNS lymphoma (PCNSL) treated with pemetrexed. 44th ASCO Annual Meeting Proceedings [Abstract]. J. Clin. Oncol. 26:2075

    Article  Google Scholar 

  • Arellano-Rodrigo, E., Lopez-Guillermo, A., Bessell, E.M., Nomdedeu, B., Montserrat, E., and Graus, F. (2003) Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma. Eur. J. Hematol. 70:219–224

    Article  CAS  Google Scholar 

  • Bessell, E.M., Graus, F., Lopez-Guillermo, A., Lewis, S.A., Villa, S., Verger E., and Petit, J. (2004) Primary non-Hodgkin's lymphoma of the CNS treated with CHOD/BVAM or BVAM chemotherapy before radiotherapy: long-term survival and prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 59:501–508

    Article  PubMed  Google Scholar 

  • Enting, R.H., Demopoulos, A., DeAngelis, L.M., and Abrey, L. (2004) Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide. Neurology 63:901–903

    Article  PubMed  CAS  Google Scholar 

  • Ferreri, A.J., Reni, M., Foppoli, M., Martelli, M., Pangalis, G.A., Frezzato, M., Cabras, M.G., Fabbri, A., Corazzelli, G., Ilariucci, F., Rossi, G., Soffietti, R., Stelitano, C., Vallisa, D., Zaja, F., Zoppegno, L., Aondio, G.M., Avvisati, G., Balzarotti, M., Brandes, A.A., Fajardo, J., Gomez, H., Guarini, A., Pinotti, G., Rigacci, L., Uhlmann, C., Picozzi, P., Vezzulli, P., Ponzoni, M., Zucca, E., Calligaris-Cappio, F., Cavalli, F. International Extranodal Lymphoma Study Group (IELSG) (2009). High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374: 1512–1520

    Article  PubMed  CAS  Google Scholar 

  • Ferreri, A.J., Reni, M., Zoldan, M.C., Terreni, M.R., and Villa, E. (1996) Importance of complete staging in non-Hodgkin’s lymphoma presenting as a cerebral mass lesion. Cancer 77:827–833

    Article  PubMed  Google Scholar 

  • Ferreri, A.J.M., Reni, M., and Villa, E. (2000) Therapeutic management of primary central nervous system lymphoma: lessons from prospective trials. Ann. Oncol. 11:927–937

    Article  PubMed  Google Scholar 

  • Ferreri, A.J.M., Reni, M., Pasini, F., Calderoni, A., Tirelli, U., Pivnik, A., Aondio, G.M., Ferrarese, F., Gomez, H., Ponzoni, M., Borisch, B., Berger, F., Chassagne, C., Iuzzolino, P., Carbone, A., Weis, J., Pedrinis, E., Motta, T., Jouvet, A., Barbui, T., Cavalli, F., and Blay, J.Y. (2002) A multicenter study of treatment of primary CNS lymphoma for the International Extranodal Lymphoma Study Group. Neurology 58:1513–1520

    Article  PubMed  Google Scholar 

  • Ferreri, A.J.M., Blay, J.Y., Reni, M., Pasini, F., Spina, M., Ambrosetti, A., Calderoni, A., Rossi, A., Vavassori, V., Conconi, A., Devizzi, L., Berger, F., Ponzoni, M., Borisch, B., Tinguely, M., Cerati, M., Milani, M., Orvieto, E., Sanchez, J., Chevreau, C., Dell'Oro, S., Zucca, E., and Cavalli, F. (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. J. Clin. Oncol. 21:266–272

    Article  PubMed  Google Scholar 

  • Fischer, L., Thiel, E., Klasen, H.A., Birkmann, J., Jahnke, K., Martus, P., and Korfel, A. (2006) Prospective trial on topotecan salvage therapy in primary CNS lymphoma. Ann. Oncol. 17:1141–1145

    Article  PubMed  CAS  Google Scholar 

  • Gavrilovic, I.T., Hormigo, A., Yahalom, J., DeAngelis, L.M., and Abrey, L.E. (2006) Long-term follow-up of high-dose methotrexate-based therapy with and without whole brain irradiation for newly diagnosed primary CNS lymphoma. J. Clin. Oncol. 24:4570–4574

    Article  PubMed  CAS  Google Scholar 

  • Glass, J., Gruber, M.L., Cher, L., and Hochberg, F.H. (1994) Preirradiation MTX chemotherapy of primary central nervous system lymphoma: long term outcome. J. Neurosurg. 81:188–195

    Article  PubMed  CAS  Google Scholar 

  • Herrlinger, U., Brugger, W., Bamberg, M., Küker, W., Dichgans, J., and Weller, M. (2000) PCV salvage chemotherapy for recurrent primary CNS lymphoma. Neurology 54:1707–1708

    Article  PubMed  CAS  Google Scholar 

  • Herrlinger, U., Kuker, W., Uhl, M., Blaicher, H.P., Karnath, H.O., Kanz, L., Bamberg, M., and Weller, M. (2005) NOA-03 Trial of high-dose MTX in primary central nervous system lymphoma: final report. Ann. Neurol. 57:843–847

    Article  PubMed  CAS  Google Scholar 

  • Hottinger, A.F., DeAngelis, L.M., Yahalom, J., and Abrey, L.E. (2007) Salvage whole brain radiotherapy for recurrent or refractory primary CNS lymphoma. Neurology 69:1178–1182

    Article  PubMed  Google Scholar 

  • Iwamoto, F.M., Schwartz, J., Pandit-Taskar, N., Peak, S., Divgi, C.R., Zelenetz, A.D., Humm, J., and Abrey, L.E. (2007) Study of radiolabeled indium-111 and yttrium-90 ibritumomab tiuxetan in primary central nervous system lymphoma. Cancer 110:2528–2534

    Article  PubMed  CAS  Google Scholar 

  • Jahnke, K., Thiel, E., Martus, P., Herrlinger, U., Weller, M., Fischer, L., and Korfel, A. German Primary Central Nervous System Lymphoma Study Group (2006) Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J. Neurooncol. 80:159–165

    Article  PubMed  Google Scholar 

  • Kiewe, P., Korfel, A., Maza, S., Jahnke, K., Munz, D.L., and Thiel, E. (2006) Penetration of Yttrium-90-labeled ibritumomab tiuxetan (ZevalinTM) into primary CNS lymphoma. 2006 ASH Annual Meeting Abstracts [Abstract] 108:2724

    Google Scholar 

  • Nguyen, P.L., Chakravarti, A., Finkelstein, D.M., Hochberg, F., Batchelor, T.T., and Loeffler, J.S. (2005) Results of whole brain radiation as salvage of MTX failure for immunocompetent patients with primary central nervous system lymphoma. J. Clin. Oncol. 23:1507–1513

    Article  PubMed  Google Scholar 

  • O’Brien, P., Roos, D., Pratt, G., Liew, K., Barton, M., Poulsen, M., Olver, I., and Trotter, G. (2000) Phase II multicentre study of brief single-agent MTX followed by irradiation in primary CNS lymphoma. J. Clin. Oncol. 18:519–526

    PubMed  Google Scholar 

  • Pels, H., Schmidt-Wolf, I.G., Glasmacher, A., Schulz, H., Engert, A., Diehl, V., Zellner, A., Schackert, G., Reichmann, H., Kroschinsky, F., Vogt-Schaden, M., Egerer, G., Bode, U., Schaller, C., Deckert, M., Fimmers, R., Helmstaedter, C., Atasoy, A., Klockgether, T., and Schlegel, U.(2003) Primary central nervous system lymphoma: results of a pilot and phase II study of systemic and intraventricular chemotherapy with deferred radiotherapy. J. Clin. Oncol. 21:4471–4473

    Article  Google Scholar 

  • Plotkin, S.R., Betensky, R.H., Hochberg, F.H., Grossman, S.A., Lesser, G.J., Nabors, L.B., Chon, B., and Batchelor, T.T. (2004) Treatment of relapsed PCNSL with high-dose methotrexate. Clin. Cancer Res. 10:5643–5646

    Article  PubMed  CAS  Google Scholar 

  • Reni, M., and Ferreri, A.J.M. (2004) Is withdrawal of consolidation radiotherapy an evidence–based strategy in primary central nervous system lymphomas? J. Clin. Oncol. 22:1165–1167

    Article  PubMed  Google Scholar 

  • Reni, M., Ferreri, A.J.M., Garancini, M.P., and Villa, E. (1997) Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: Results of a critical review of the literature. Ann. Oncol. 8:227–234

    Article  PubMed  CAS  Google Scholar 

  • Reni, M., Ferreri, A.J.M., and Villa, E. (1999) Second-line treatment for primary central nervous system lymphoma. Br. J. Cancer 79:530–534

    Article  PubMed  CAS  Google Scholar 

  • Reni, M., Ferreri, A.J.M., Guha-Thakurta, N., Blay, J.Y., Dell’Oro, S., Biron, P., and Hochberg, F.H. (2001) The clinical relevance of consolidation radiotherapy and other main therapeutic issues in primary central nervous system lymphomas treated with upfront high-dose methotrexate. Int. J. Radiat. Oncol. Biol. Phys. 51:419–425

    Article  PubMed  CAS  Google Scholar 

  • Reni, M., Mason, W., Zaja, F., Perry, J., Franceshi, E., Bernardi, D., Dell’Oro, S., Stelitano, C., Candela, M., Abbadessa, A., Pace, A., Bordonaro, R., Latte, G., Villa, E., and Ferreri, A.J.M. (2004) Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial. Eur. J. Cancer 40:1682–1688

    Article  PubMed  CAS  Google Scholar 

  • Reni, M., Zaja, F., Mason, W., Perry, J., Mazza, E., Spina, M., Bordonaro, R., Ilariucci, F., Faedi, M., Corazzelli, G., Manno, P., Franceschi, E., Pace, A., Candela, M., Abbadessa, A., Stelitano, C., Latte, G., and Ferreri, A.J.M. (2007) Temozolomide as salvage treatment in primary brain lymphomas. Br. J. Cancer 96:864–867

    Article  PubMed  CAS  Google Scholar 

  • Rodriguez, M.A., Cabanillas, F.C., Hagemeister, F.B., McLaughlin, P., Romaguera, J., Swan, F., and Velasquez, W.S. (1995) A phase II trial of mesna/ifosfamide, mitoxantrone and etoposide for refractory lymphomas. Ann. Oncol. 6:609–611

    PubMed  CAS  Google Scholar 

  • Rubenstein, J.L., Fridlyand, J., Abrey, L., Shen, A., Karch, J., Wang, E., Issa, S., Damon, L., Prados, M., McDermott, M., O’Brien, J., Haqq, C., and Shuman, M. (2007) Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma. J. Clin. Oncol. 25:1350–1356

    Article  PubMed  CAS  Google Scholar 

  • Ruhstaller, T.W., Amsler, U., and Cerny, T. (2000) Rituximab: active treatment of central nervous system involvement by non-Hodgkin’s lymphoma? Ann. Oncol. 11:374–375

    Article  PubMed  CAS  Google Scholar 

  • Shapiro, W.R., Young DF, Mehta BM. (1975) Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med 293: 161–166

    Article  PubMed  CAS  Google Scholar 

  • Soussain, C., Suzan, F., Hoang-Xuan, K., Casasnovas, O., Dupriez, B., Taksin, A.L., Souleau, B., Kolb, B., Jaccard, A., Zini, J.M., Choquet, S., Witz, F., Janvier, M., and Leblond, V. (2001) Results of intensive chemotherapy followed by hematopietic stem-cell rescue in 22 patients with refractory or recurrent primary CNS lymphoma or intraocular lymphoma. J. Clin. Oncol. 19:742–749

    PubMed  CAS  Google Scholar 

  • Soussain, C., Hoang-Xuan, K., Taillandier, L., Fourme, E., Choquet, S., Witz, F., Casasnovas, O., Dupriez, B., Souleau, B., Taksin, A.L., Gisselbrecht, C., Jaccard, A., Omuro, A., Sanson, M., Janvier, M., Kolb, B., Zini, J.M., and Leblond, V. (2008) Intensive chemotherapy followed by hematopoietic stem-cell rescue for refractory and recurrent primary CNS and intraocular lymphoma: Société Française de Greffe de Moëlle Osseuse-Thérapie Cellulaire. J. Clin. Oncol. 26:2512–2518

    Article  PubMed  Google Scholar 

  • Tyson, R. M., Siegal, T., Doolittle, N.D., Lacy, C., Kraemer, D.F., and Neutwelt, E.A. (2003) Current status and future of relapsed primary central nervous system lymphoma (PCNSL). Leuk. Lymphoma 44:627–633

    Article  PubMed  CAS  Google Scholar 

  • Velasquez, W.S., McLaughlin, P., Tucker, S., Hagemeister, F.B., Swan, F., Rodriguez, M.A., Romaguera, J., Rubenstein, E., and Cabanillas, F. (1994) ESHAP Ð an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study. J. Clin. Oncol. 12:1169–1176

    PubMed  CAS  Google Scholar 

  • Voloschin, A.D., Betensky, R., Wen, P.Y., Hochberg, F., and Batchelor, T. (2008) Topotecan as salvage therapy for relapsed or refractory primary central nervous system lymphoma. J. Neurooncol. 86:211–215

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Oncology Unit, Department of Oncology, San Raffaele Scientific Institute, via Olgettina 60, 20132, Milan, Italy

    Michele Reni, Elena Mazza & Andrés J. M. Ferreri

Authors
  1. Michele Reni
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elena Mazza
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Andrés J. M. Ferreri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michele Reni .

Editor information

Editors and Affiliations

  1. Dept. Biological Sciences, Kean University, Union, 07083, New Jersey, USA

    M. A. Hayat

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Netherlands

About this chapter

Cite this chapter

Reni, M., Mazza, E., Ferreri, A.J.M. (2011). Primary Central Nervous System Lymphomas: Salvage Treatment. In: Hayat, M. (eds) Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 8. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-8665-5_26

Download citation

  • DOI: https://doi.org/10.1007/978-90-481-8665-5_26

  • Published:

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-90-481-8664-8

  • Online ISBN: 978-90-481-8665-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation